CovalX team will be attending PEGS Boston 2026 – The Essential Protein Engineering Summit, running from May 11-15, 2026, at the Omni Boston Hotel at the Seaport, Boston, MA, one of the world’s premier conferences focused on biologics, protein science, and therapeutic innovation.
PEGS Boston 2026 will feature 350+ scientific presentations, interactive breakout sessions, training seminars, and an extensive exhibit hall, providing attendees with unparalleled opportunities to learn, collaborate, and explore transformative technologies in protein and antibody engineering. New for 2026, the conference will include expanded coverage of peptide therapeutics, AI-driven biologics research, immunotherapy, and next-generation drug development modalities.
The CovalX team will be available at Booth #220 to showcase our advanced mass-spectrometry-based solutions for biotherapeutic characterization, including epitope mapping by mass spectrometry, de novo Sequencing, mAb characterization. Visit our booth to discuss how CovalX technologies can accelerate discovery, improve biologic characterization, and support your research and development workflows.
We look forward to connecting with researchers, partners, and industry professionals at PEGS Boston 2026 and discussing how CovalX can support your next breakthrough in biologics research. Contact us at info@covalx.com.